Mucoadhesive vaginal drug delivery systems

Recent Patents on Drug Delivery and Formulation

Volumn 3, Issue 3, 2009, Pages 193-205

  Acartürk, Füsun ^a  

^a GAZI UNIVERSITY   (Turkey)

Author keywords

Bioadhesion; Cellulose derivatives; Chitosan; Film; Gel; Mucoadhesion; Pessary; Polyacrylates; Polycarbophil; Suppository; Tablet; Thermoreversible gel; Vaginal

Indexed keywords

ACRYLIC ACID; ADVANTAGE S; CARBOMER; CARBOPOL 974P; CARRAGEENAN; CELLULOSE DERIVATIVE; CHITIN DERIVATIVE; CHITOSAN; CLINDAMYCIN; CLOTRIMAZOLE; ECONAZOLE; FENTICONAZOLE; GLYCEROL; HYDROXYETHYLCELLULOSE; IMIDAZOLE DERIVATIVE; ISOCONAZOLE; METHYL PARABEN; METRONIDAZOLE; MICONAZOLE; MICROBICIDE; NONOXINOL 9; POLYACRYLIC ACID; POLYCARBOPHIL; PROGESTERONE; PROSTAGLANDIN E2; PYRAN COPOLYMER; SERTACONAZOLE; SODIUM CHLORIDE; TERCONAZOLE; TIOCONAZOLE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

BACTERIAL INFECTION; CONTRACEPTION; CREAM; DRUG ADMINISTRATION ROUTE; DRUG DELIVERY SYSTEM; DRUG FORMULATION; EMULSION; FILM COATING; GEL; HUMAN; INFERTILITY; LUBRICATION; MUCOADHESION; MUCOSAL DISEASE; MYCOSIS; NONHUMAN; PARASITOSIS; PATENT; PH; PRIORITY JOURNAL; REVIEW; SECONDARY AMENORRHEA; SUPPOSITORY; SUSTAINED RELEASE FORMULATION; VAGINA CANDIDIASIS; VAGINA PAIN; VAGINA PESSARY; VAGINAL DRYNESS; VAGINITIS; VIRUS INFECTION;

ADHESIVENESS; ADMINISTRATION, INTRAVAGINAL; DRUG DELIVERY SYSTEMS; FEMALE; GELS; HUMANS; PHARMACEUTICAL PREPARATIONS; TABLETS; TECHNOLOGY, PHARMACEUTICAL; VAGINA; VAGINAL DISEASES;

EID: 70350762116     PISSN: 18722113     EISSN: None     Source Type: Journal    
DOI: 10.2174/187221109789105658     Document Type: Review

References (112)

1. Valenta C. The use of mucoadhesive polymers in vaginal delivery. Adv Drug Deliv Rev 2005; 57: 1692-1712.
2. Knuth K, Amiji M, Robinson JR. Hydrogel delivery systems for vaginal and oral applications. Formulation and biological considerations. Adv Drug Deliv Rev 1993; 11: 137-167.
3. Robinson JR, Bologna WJ. Vaginal and reproductive system treatments using a bioadhesive polymer. J Control Release 1994; 28: 87-94.
4. Brannon-Peppas L. Novel vaginal drug release applications. Adv Drug Deliv Rev 1993; 11: 169-177.
5. das Neves J, Bahia MF. Gels as vaginal drug delivery systems. Int J Pharm 2006; 318: 1-14.
6. Acartürk F, Robinson JR. Vaginal permeability and enzymatic activity studies in normal and ovariectomized rabbits. Pharm Res 1996; 13: 779-783.
7. Acartürk F, Parlatan ZI, Saracoǧlu ÖF. Comparison of vaginal aminopeptidase enzymatic activities in various animals and humans. J Pharm Pharmacol 2001; 53: 1499-1504.
8. Acartürk F, Altuǧ N. in vitro and in vivo Evaluation of a matrix-controlled bromocriptine mesilate-releasing vaginal ring. J Pharm Pharmacol 2000; 53: 1721-1726.
9. Deǧim T, Tugcu-Demiroz F, Tamer-Ilbasmiǧ S, Acarturk F. Development of controlled release sildenafil formulations for vaginal administration. Drug Deliv 2008; 15: 259-265.
10. Christensen FC, Tehranifar JL, Gonzales CR, Qualls VJ, Rappaport VJ, Rayburn WF. Randomized trial of concurrent oxytocin with a sustained-release dinoprostone vaginal insert for labor induction at term. Am J Obstet Gynecol 2002; 186: 61-65.
11. Nakada Y, Miyake M, Awata N. Some factors affecting the vaginal absorption of human calcitonin in rats. Int J Pharm 1993; 89: 169-175.
12. Okada H, Yashiki T, Mima H. Vaginal absorption of a potent luteinizing hormone-releasing hormone analogue(leuprolide) in rats III. Effect of estrous cycle on vaginal absorption of hydrophilic model compounds. J Pharm Sci 1983; 72: 173-176.
13. Richardson JL, Illum L. The vaginal route of peptide and protein drug delivery. Adv Drug Deliv Rev 1992; 8: 341-366.
14. Deǧim Z, Deǧim T, Acartürk F, Erdoǧan D, Özoǧul C, Köksal M. Rectal and vaginal administration of insulin-chitosan formulations: An experimental study in rabbits. J Drug Target 2005; 13: 563-572.
15. Schröder A, Levin RM, Kogan BA, Das AK, Kay F, Mahashabde A. Absorption of oxybutynin from vaginal inserts: Drug blood levels and the response of the rabbit bladder. Urology 2000; 56: 1063-1067.
16. Tugcu-Demiröz F, Acartürk F. Preparation of controlled release oxybutynin containing bioadhesive vaginal gel. 6th World Meeting on Pharmaceutics Biopharmaceut Pharmaceut Technol. Barcelona: Spain 2008.
17. Ziegler D, Fanchin R, Progestrone and progestin applications in gynecology. Steroids 2000; 65: 671-679.
18. Calis S, Sumnu M, Hincal M. Effect of suppository bases on the release properties of a potent antimicrobial agent (C31G). Pharmazie 1994; 49: 336-339.
19. Voorspoels J, Casteels M, Remon JP, Temmerman M. Local treatment of bacterial vaginosis with a bioadhesive metronidazole tablet. Eur J Obstet Gynecol Reprod Biol 2002; 105: 64-66.
20. Ozyazici M, Turgut EH, Taner MS, Köseoǧlu K, Ertan G. in vitro Evaluation and vaginal absorption of metronidazole suppositories in rabbits. J Drug Target 2003; 11:177-185.
21. Ozer O, Ozyazici M, Tedajo M, Taner MS, Koseoglu K. W/O/W multiple emulsion containing nitroimidazole derivatives for vaginal delivery. Drug Deliv 2007; 14: 139-145.
22. Baloǧlu E, Özyazici M, Hizarcioǧlu SY, ǧenyiǧit T, Özyurt D, Pekçetin C. Bioadhesive controlled release systems of ornidazole for vaginal delivery. Pharm Dev Technol 2006; 11: 477-484.
23. Wang L, Tang X. A novel ketoconazole bioadhesive effervescent tablet for vaginal delivery: Design, in vitro and in vivo evaluation. Int J Pharm 2008; 350: 181-187.
24. Karasulu HY, Hilmioǧlu S, Metin DY, Güneri T. Efficacy of a new ketoconazole bioadhesive vaginal tablet on Candida albicans. IL Farmaco 2004; 59: 163-167.
25. Albertini B, Passerini N, Sabatino MD, Vitali B, Brigidi P, Rodriguez L. Polymer-lipid based mucoadhesive microspheres prepared by spray-congealing for the vaginal delivery of econazole nitrate. Eur J Pharm Sci 2009; 36: 591-601.
26. Genç L, Oǧuzlar C, Güler E. Studies on vaginal bioadhesive tablets of acyclovir. Pharmazie 2000; 55: 297-299.
27. Tugcu-Demiröz F, Acartürk F. Controlled release of cidofovir from bioadhesive vaginal chitosan gel. 4th Int Pharmaceut Technol Symp, Antalya-Turkey 2008.
28. Acartürk F, Robinson JR. Effect of the spermicide, nonoxynol 9, on vaginal permeability in normal and ovariectomized rabbits. Pharm Res 1996; 13: 950-951.
29. Valenta C, Kast CE, Harich I, Bernkop-Schnürch A. Development and in vitro evaluation of a mucoadhesive vaginal delivery system for progesterone. J Control Release 2001; 77: 323-332.
30. Vermani K, Garg S. The scope and potential of vaginal drug delivery. Pharm Sci Technol Today 2000; 359-364.
31. Park K, Robinson JR. Physicochemical properties of water insoluble polymers important to mucin/epithelial adhesion. J Control Release 1985; 2: 47-57.
32. Andrews GP, Laverty TP, Jones DS. Mucoadhesive polymeric platforms for controlled drug delivery. Eur J Pharm Biopharm 2009; 71: 505-518.
33. Leung S, Robinson JR. Polymer structure features contributing to mucoadhesion. II. J Control Release 1990; 12: 187-194.
34. Park K, Robinson JR. Bioadhesive polymers as platforms for oral-controlled drug delivery: Method to study bioadhesion. Int J Pharm 1984; 19: 101-127.
35. Park K, Robinson JR. Mechanism of mucoadhesion of poly(acrylic acid) hydogels. Pharm Res 1987; 4: 457-464.
36. Leung S, Robinson JR. The contribution of anionic polymer structural features to mucoadhesion. J Control Release 1988; 5: 223-231.
37. Nagai T. Adhesive topical drug delivery systems. J Control Release 1985; 2: 121-134.
38. Ponchel G, Touchard F, Duchene D, Peppas NA. Bioadhesive analysis of controlled-release systems. I. Fracture and interpenetration analysis in poly(acrylic acid)-containing systems. J Control Release 1987; 5: 129-141.
39. Peppas NA, Ponchel G, Duchene D. Bioadhesive analysis of controlled-release systems. II. Time dependent bioadhesive stress in poly (acrylic acid)- containing systems. J Control Release 1987; 5: 143-149.
40. Mauck CK, Katz D, Sandefer EP, et al. Vaginal distribution of Replens® and K-Y® Jelly using three imaging techniques. Contraception 2008; 77: 195-204.
41. Bonacucina G, Martelli S, Palmieri GF. Rheological, mucoadhesive and release properties of carbopol gels in hydrophilic cosolvent. Int J Pharm 2004; 282: 115-130.
42. Gürsoy A, Sohtorik I, Uyanik N, Peppas NA. Bioadhesive controlled release systems for vaginal delivery. STP Pharma 1989; 5: 886-892.
43. Owen DH, Peters JJ, Katz DF. Rheological properties of contraceptive gels. Contraception 2000; 62: 321-326.
44. Lehr CM, Bouwstra JA, Schacht EH, Junginger HE. in vitro Evaluation of mucoadhesive properties of chitosan and some other natural polymers. Int J Pharm 1992; 78: 43-48.
45. Kamel AE, Sokar M, Naggar V, Gamal SA. Chitosan and sodium alginate-based bioadhesive vaginal tablets. AAPS Pharm Sci 2002; 4: 1-7.
46. Perioli L, Ambrogi V, Venezia L, Pagano C, Ricci M, Rossi C. Chitosan and a modified chitosan as agents to improve performances of mucoadhesive vaginal gels. Colloids Surface B: Biointerfaces 2008; 66: 141-145.
47. Ramadan AA. Formulation and evaluation of bioadhesive gels containing miconazole nitrate. J Appl Sci Res 2008; 4: 1052-1065.
48. Sharma G, Jain S, Twary AK, Kaur G. Once daily bioadhesive vaginal clotrimazole tablets: Design and evaluation. Acta Pharm 2006; 56: 337-345.
49. Barnhart K, Kulp JL, Rosen M, Shera DM. A randomized trial to determine the distribution of four topical gel formulations in the human vagina. Contraception 2009; 79(4): 297-303.
50. Kast CE, Valenta C, Leopold M, Bernkop-Schnürch A. Design and in vitro evaluation of a novel bioadhesive vaginal drug delivery system for clotrimazole. J Control Release 2002; 81: 347-354.
51. Robinson, J.R.: EP0431719 (1991).
52. Robinson, J.R.: US5474768 (1995).
53. Robinson, J.R.: RU2104034 (1998).
54. Meignant, C., Vieillard-Baron, C.: WO9712618 (1997).
55. Giroux, J.M.: WO9403186 (1994).
56. Durrani, M.J.: WO20060047144 (2006).
57. Fernandez, A.A., Garcia, A.C., Hernandez, M.R.M., Gartua, O.M., Pedraz, M.J.L., Rodriguez, G.A.: US2006240111 (2006).
58. Robinson, J.R., Bologna, W.J.: US20006017521 (2000).
59. Polona, W.J.: CN1246333 (2000).
60. Saettone, M.F., Panichi, L., Giannaccini, B., Boldrini, E., Bianchini, P.: US2002012674 (2002).
61. Daugustine, M.A., Liu, J.H., Harrison, D.C.: WO20050203896 (2005).
62. Bologna, W.J., Levine, H.L.: WO037382 (2003).
63. Bologna, W.J., Levine, H.L.: NZ532294 (2006).
64. Larsen, B.: WO9715314 (1997).
65. Larsen, B.: US5958461 (1999).
66. Bortz, J., Levinson, R.S., Kirschner, M., Cuca, R.: US2006140990 (2006).
67. Palacin, C., Guerrero, M., Raga, M.M., Romero, A., Gulieetta, A.: US2006165803 (2006).
68. Meignant, C.: WO9619195 (1996).
69. Meignant, C.: BG101660 (1998).
70. Prini, M.: US2007031479 (2007).
71. Tzachev, C.T., Popov, T.A.: WO070213 (2003).
72. Caramella, C.M., Bonferoni, M.C., Giunchedi, P.: US2004132690 (2004).
73. Zhao, X., Burd, K.A.: WO2009066102 (2009).
74. Roy S, Gourde P, Piret J, et al. Thermoreversible gel formulations containing sodium lauryl sulfate or n-lauroylsarcosine as potential topical microbicides against sexually transmitted diseases. Antimicrob Agents Chem 2001; 45: 1671-1681.
75. Chang JY, Oh YK, Choi HG, Kim YB, Kim CK. Rheological evaluation of thermosensitive and mucoadhesive vaginal gels in physiological conditions. Int J Pharm 2002; 241: 155-163.
76. Tirnaksiz F, Robinson JR. Rheological mucoadhesive and release properties of pluronic F-127 gel and pluronic F-127/polycarbophil mixed gel systems. Pharmazie 2005; 60: 518-523.
77. Bilensoy E, Rouf MA, Vural I, Sen M, Hincal AA. Mucoadhesive, thermosensitive, prolonged-release gel for clotrimazole: β-cyclodextrin complex. AAPS Pharm SciTech 2006; 7: E1-E7.
78. Bilensoy E, Cirpanli Y, Murat S, Dogan A, Calis S. Thermosensitive mucoadhesive gel formulation loaded with 5-Fu cyclodextrin complex for HPV-induced cervical cancer. J Inc Phen Macrocyc Chem 2007; 57: 363-370.
79. Auzerie, J.: US2003091642 (2003).
80. Brache V, Croxatto H, Kumar N, et al. Effect of sexual intercourse on the absorption of levonorgestrel after vaginal administration of 0.75mg in Carraguard® gel: A randomized, cross-over, pharmacokinetic study. Contraception 2009; 79: 150-154.
81. Hussain A, Ahsan F. The vagina as a route for systemic drug delivery. J Control Release 2005; 103: 301-313.
82. Perioli L, Ambrogi V, Pagano C, Scuota S, Rossi C. FG90 chitosan as a new polymer for metronidazole mucoadhesive tablets for vaginal administration. Int J Pharm 2009; (in press) DOI 10.1016/ j.ijpharm.2009.05016
83. De Luigi, B.S., Mailland, F.: WO2008000683 (2008).
84. Conte, U., Maggi, L.: WO9302662 (1993).
85. Puri, R., Zhang Y., Foreman, P.B.: EP1757267 (2007).
86. Gilis, P.M.C.: US20016303147 (2001).
87. Stone, A., Neurath, A.R., Strick, N., Jiang, S.: WO2008148018 (2008).
88. Sen, N., Prasath, K.A., Bhonsle, S., Krishnan, A.: WO2005107702 (2005).
89. Lemarchand, C.: EP1972332 (2008).
90. Repka, M.A., Repka, S.L., Mcginity, J.W.: US20026375963 (2002).
91. Pauletti, G.M., Desai, K.J., Roweton, S.L., Harrison, D.C., Sanders, L.M.: WO2007041118 (2007).
92. Maniar, M., Parandoosh, S.: WO2005013906 (2005).
93. Wilson, M., Desai, K.J., Pauletti, G.M., Antoon, M.K.J.R., Clendening, C.E.: WO20060117341 (2006).
94. Santus, G., Bottoni, G., Sala, G.: EP0516141 (1992).
95. Paris, L.: US2008274191 (2008).
96. Hansen, J., Sylvest, N.L., Norling, T.: WO9526715 (1995).
97. Hansen, J., Sylvest, N.L., Norling, T.: US5955502 (1999).
98. Hansen, J., Sylvest, N. L., Norling, T.: US20016228383 (2001).
99. Perioli L, Ambrogi V, Venezia L, Pagano C, Giovagnoli S, Rossi C. Formulation studies of benzydamine mucoadhesive formulations for vaginal administration. Drug Dev Ind Pharm 2009; DOI 10.1080/03639048022592435 [Epub ahead of print].
100. Friedman, D., Schwarz, J., Amselem, S.: US5514670 (1995).
101. Putteman, P., Francois, M.K.J., Snoeckx, E.C.L., US5814330 (1998).
102. Kirschner, M.S.L.: US2003180366 (2003).
103. Payne, N., Timmins, P.: DE3800256 (1988).
104. Brummer, B., Swick P., Link, M., Hart, W.: CA2178566 (1996).
105. Darwish, A.M.M.: WO2006099877 (2006).
106. Darwish, A.M.M.: WO2006125450 (2006).
107. Embil, K., Baktir, G., Figueroa, R.: WO2005087270 (2005).
108. Pather, S.I., Robinson, J.R., Eichman, J.D., Khankari, R.K., Hontz, J.: US2005037072 (2005).
109. Pauletti, G.M., Clendening, C.E.: WO2004067063 (2004).
110. Mathias, N.R., Li, L.: WO2005115339 (2005).
111. Pauletti, G.M., Wilson, M., Soderstrom, R., Desai, K.J., Ritschel, W.A.: US2005249774 (2005).
112. Ipsen, H.H., Uldal, R.J.: CA2361377 (2000).